Edition:
India

Aspen Pharmacare Holdings Ltd (APNJ.J)

APNJ.J on Johannesburg Stock Exchange

27,075.00ZAc
22 Feb 2018
Change (% chg)

-- (--)
Prev Close
27,075.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,582,630
52-wk High
32,750.00
52-wk Low
23,498.00

Chart for

About

Aspen Pharmacare Holdings Limited is a South Africa-based supplier and manufacturer of branded and generic pharmaceutical products, as well as infant nutritional and consumer healthcare products. The Company's segments include International, South Africa, Asia Pacific and Sub-Saharan Africa (SSA). Its International business... (more)

Overall

Beta: 0.56
Market Cap(Mil.): R139,674.20
Shares Outstanding(Mil.): 456.45
Dividend: 287.00
Yield (%): 0.94

Financials

  Industry Sector
P/E (TTM): -- 31.10 16.60
EPS (TTM): -- -- --
ROI: -- 14.90 10.66
ROE: -- 16.41 14.30

BRIEF-Aspen Expects HY HEPS Between 820.4 To 846.0 Cents Per Share​

* EXPECTS HY HEADLINE EARNINGS PER TO IMPROVE 28% TO 32% BETWEEN 820.4 TO 846.0 CENTS PER SHARE​ Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

15 Feb 2018

South Africa's Aspen to start review of infant milk formula unit

JOHANNESBURG, Jan 29 Aspen Pharmacare will review its infant milk formula business with options including a sale to a strategic partner, Africa's biggest generic drugmaker said on Monday.

29 Jan 2018

BRIEF-Aspen Says To Review Global Nutritionals Business

* ‍HAS BEEN EXPLORING OPTIONS TO ENHANCE VALUE OF ITS GLOBAL NUTRITIONALS BUSINESS ("NUTRITIONALS") SINCE RECEIVING AN UNSOLICITED APPROACH IN Q3 OF LAST YEAR​

29 Jan 2018

Drugmaker GSK cuts back in Africa to hone emerging markets model

LONDON, Jan 17 GlaxoSmithKline is cutting back operations in Africa as its new Chief Executive Emma Walmsley seeks to make the British drugmaker more competitive in emerging markets by ditching her predecessor's expansion plans for the continent.

17 Jan 2018

BRIEF-Aspen Pharmacare Receives Approval For Registration Of Alula In China​

* ‍ASPEN RECEIVES APPROVAL FOR REGISTRATION OF ALULA IN CHINA​ Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

15 Jan 2018

BRIEF-Aspen Pharmacare Says Has Had No Contact With Viceroy Research

* HAS HAD NO CONTACT WITH VICEROY RESEARCH AND, AS SUCH, IS UNABLE TO CONFIRM THAT SPECULATION IS CORRECT

09 Jan 2018

UK anti-trust regulator investigates South Africa's Aspen Pharmacare

JOHANNESBURG Britain's competition regulator has launched an investigation into Africa's biggest generic drug maker Aspen Pharmacare over alleged anticompetitive conduct in the supply of blood pressure and arthritis drugs, Aspen said on Friday.

13 Oct 2017

UK anti-trust regulator investigates S.Africa's Aspen Pharmacare

JOHANNESBURG, Oct 13 Britain's competition regulator has launched an investigation into Africa's biggest generic drug maker Aspen Pharmacare over alleged anticompetitive conduct in the supply of blood pressure and arthritis drugs, Aspen said on Friday.

13 Oct 2017

South Africa watchdog drops over-charging probe into Aspen, Equity

JOHANNESBURG South Africa's competition watchdog has dropped an investigation into Aspen Pharmacare and Equity Pharmaceutical, saying a case against them for over-charging for cancer medicines "cannot be sustained."

04 Oct 2017

UPDATE 1-S.Africa watchdog drops over-charging probe into Aspen, Equity

JOHANNESBURG, Oct 4 South Africa's competition watchdog has dropped an investigation into Aspen Pharmacare and Equity Pharmaceutical, saying a case against them for over-charging for cancer medicines "cannot be sustained."

04 Oct 2017

Earnings vs. Estimates